Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The effects of prolonged wear of textured shoe insoles on gait, foot sensation and proprioception in people with multiple sclerosis: study protocol for a randomised controlled trial.
The role of pre-morbid intelligence and cognitive reserve in predicting cognitive efficiency in a sample of Italian elderly.
Betaseron (Interferon Beta-1b) for SC Injection
Dimethyl Fumarate and Monoethyl Fumarate Exhibit Differential Effects on KEAP1, NRF2 Activation, and Glutathione Depletion In Vitro.
Sema4A inhibits the therapeutic effect of IFN-β in EAE.
Interferon-beta1b for the treatment of multiple sclerosis.
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells.
Implications of Real-world Adherence on Cost-effectiveness Analysis in Multiple Sclerosis.
Testing the measurement invariance of the University of Washington Self-Efficacy Scale short form across four diagnostic subgroups.
Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects.
Genetic analysis of aquaporin-4 in neuromyelitis optica.
Long-term Impact of Early MS Treatment with Interferon Beta-1b (IFNB-1b): Clinical, MRI, Employment, and Patient-Reported Outcomes (PROs) at the 11-Year Follow-up of BENEFIT (BENEFIT 11)
Immunopathology: autoimmune glial diseases and differentiation from multiple sclerosis.
Clinical Reasoning: Left hemiparesis, ataxia, and optic neuritis in a child previously treated for pineoblastoma.
Avonex drug warning letter, severe hypatic injury
Some recent advances in multiple sclerosis.
A Multiple-Dose, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group QT/QTc Study to Evaluate the Electrophysiologic Effects of THC/CBD Spray.
Novantrone
[Information processing speed and influential factors in multiple sclerosis].
Improvements in cognition, quality of life, and physical performance with clinical Pilates in multiple sclerosis: a randomized controlled trial.
Clobetasol promotes remyelination in a mouse model of neuromyelitis optica.
Detailed results from Biogen Idec and AbbVie's pivotal Phase 3 DECIDE study further define the efficacy and safety profile of ZINBRYTA™ (daclizumab high-yield process)
Teriflunomide
[Neurophysiology in Guillain-Barré syndrome].
Myelinating satellite oligodendrocytes are integrated in a glial syncytium constraining neuronal high-frequency activity.

Pages